Based on proforma financials of non-energy business Siemens, the stock is currently trading at a P/E of 54x/44x/38x on FY25E/FY26E/FY27E EPS. Motilal Oswal values the stock at 45x on Mar’27E EPS and maintain Neutral rating with a target price of Rs 3,200. Valuation multiples for non-energy segment are lower than the energy segment due to lower growth profile vs energy segment.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Siemens Ltd.'s results were below our estimates for the combined company as well as the non-energy entity in Q2 FY25. For the combined entity, revenue was 6% below our estimate and PAT was 10% above our estimate. For the non-energy entity too, growth was impacted by weak execution and margin across segments, except Smart Infrastructure.
Digital Industries segment continued to see demand slowdown. Order inflows for the non-energy entity were healthy during the quarter and were up by 44% YoY, which provides good revenue visibility for future.
We cut our estimates to bake in weak performance seen during H1 FY25. Our target price of Rs 3,200 is based on 45x Mar’27E earnings on proforma financials of the non-energy entity Siemens Limited.
We will revisit our estimates once we have detailed financials of both the entities. We maintain Neutral rating on the stock.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

JB Chemicals' Acquisition Strategically Positive For Torrent Pharma, Says Motilal Oswal — Maintains 'Neutral'


Bajaj Auto Q4 Review: Motilal Oswal Maintains 'Neutral', Says KTM Turnaround To Be Among The Key Monitorables

.jpg?rect=0%2C0%2C3500%2C1969&w=75)
KEC International Q4 Review: Motilal Oswal Maintains 'Neutral' On Inline Revenue, Ebitda; Hikes Target Price


Torrent Pharma Q4 Review: Motilal Oswal Maintains 'Neutral', Says Current Valuation Factors In Earnings Upside
